Osaic Holdings
IHE icon

Osaic Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Osaic Holdings’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$958K Sell
9,673
-27,809
-74% -$2.51M ﹤0.01% 3046
2026
Q1 		$3.25M Sell
37,482
-5,190
-12% -$454K ﹤0.01% 1677
2025
Q4 		$3.62M Buy
42,672
+33,110
+346% +$2.64M 0.01% 1624
2025
Q3 		$681K Sell
9,562
-332
-3% -$22.9K ﹤0.01% 3157
2025
Q2 		$650K Buy
9,894
+1,629
+20% +$106K ﹤0.01% 2887
2025
Q1 		$584K Sell
8,265
-14,538
-64% -$1.01M ﹤0.01% 2726
2024
Q4 		$661K Buy
22,803
+16,371
+255% +$1.13M ﹤0.01% 2542
2024
Q3 		$454K Sell
6,432
-10,150
-61% -$707K ﹤0.01% 2963
2024
Q2 		$1.1M Buy
16,582
+194
+1% +$12.7K ﹤0.01% 2127
2024
Q1 		$1.11M Buy
16,388
+1,817
+12% +$120K ﹤0.01% 2234
2023
Q4 		$901K Sell
14,571
-23,595
-62% -$1.39M ﹤0.01% 2623
2023
Q3 		$2.25M Buy
38,166
+5,235
+16% +$321K ﹤0.01% 1890
2023
Q2 		$1.97M Buy
32,931
+231
+0.7% +$13.7K ﹤0.01% 1886
2023
Q1 		$1.91M Buy
32,700
+17,745
+119% +$1.07M ﹤0.01% 1858
2022
Q4 		$929K Sell
14,955
-1,113
-7% -$66.9K ﹤0.01% 2438
2022
Q3 		$908K Sell
16,068
-2,640
-14% -$163K ﹤0.01% 2330
2022
Q2 		$1.2M Sell
18,708
-8,616
-32% -$547K ﹤0.01% 2107
2022
Q1 		$16M Buy
27,324
+9,240
+51% +$586K 0.03% 532
2021
Q4 		$1.2M Sell
18,084
-26,448
-59% -$1.68M ﹤0.01% 2230
2021
Q3 		$2.72M Buy
44,532
+26,985
+154% +$1.72M 0.01% 1468
2021
Q2 		$1.09M Sell
17,547
-231
-1% -$14K ﹤0.01% 2282
2021
Q1 		$1.05M Sell
17,778
-2,082
-10% -$126K ﹤0.01% 2184
2020
Q4 		$1.19M Sell
19,860
-570
-3% -$32.5K ﹤0.01% 1886
2020
Q3 		$1.11M Sell
20,430
-4,785
-19% -$258K ﹤0.01% 1745
2020
Q2 		$1.29M Buy
25,215
+6,186
+33% +$311K ﹤0.01% 1555
2020
Q1 		$856K Buy
+19,029
New +$960K ﹤0.01% 1656

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Osaic Holdings's IHE Position: Q2 2026 in Review

Osaic Holdings reduced its iShares US Pharmaceuticals ETF (IHE) stake by 74% in Q2 2026, selling an estimated $2.51M and leaving 9,673 shares worth $958K. The position accounts for ﹤0.01% of the portfolio, ranked #3046.

Osaic Holdings first reported a position in IHE in Q1 2020 and has held it in 26 quarters since. The position peaked at $16M in Q1 2022. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Osaic Holdings held 9,673 shares of iShares US Pharmaceuticals ETF worth $958K as of Q2 2026.
  • Osaic Holdings sold 27,809 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $2.51M.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3046 holding.
  • Osaic Holdings first reported a position in iShares US Pharmaceuticals ETF in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's iShares US Pharmaceuticals ETF position peaked at $16M in Q1 2022.
  • 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.